Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By activating these https://minaedlu486793.mybloglicious.com/56235146/tirzepatide-a-promising-new-treatment-for-obesity